St. Louis, MO, April 27, 2007 --(PR.com
)-- Fig., the exclusive provider of Advanced LipoDissolve™, announced today Kevin M. Hassey has joined the advisory board of the company. Hassey, former President of LCA – Vision, brings a wealth of experience in managing retail healthcare to fig.
“Fig. is honored to have Kevin Hassey join our advisory board,” Rob Semaan, Chief Executive Officer of fig. said. “He brings an incredible breadth of knowledge around marketing and the elective healthcare industry. Kevin’s leadership and management experience is already proving to be a tremendous asset to the company.”
Hassey served as President of LCA-Vision from 2003 to 2005, recruited to strengthen marketing and grow sales revenue. During this time, Hassey helped LCA-Vision’s (NASDAQ: LCAV) revenue grow from $61 million in 2002 ($1.52 per share) to more than $175 million in 2005 ($47.51 per share). Previous to LCA-Vision, Hassey served as Vice President for the EyeMed Managed Care Division of Luxottica Group, as well as Vice President of Marketing of Luxottica’s LenCrafters division. Hassey also worked in brand management with The Procter & Gamble Company.
“The tremendous growth and success that fig. has achieved in just the 19 months since its founding is remarkable,” Hassey said. “What is even more impressive is the opportunity ahead.”
Fig. is the market leader in medically supervised body shaping, and is the exclusive provider of Advanced LipoDissolve™. Fig. currently operates and manages centers in St. Louis, Kansas City, Las Vegas, Scottsdale and Houston, with plans in 2007 to expand to Atlanta, Dallas, and Los Angeles.
For more information about fig., visit www.fig.com.
Contact: Jean Shepherd
VP of Marketing